Caramona M M, Osswald W
Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):396-400. doi: 10.1007/BF00692907.
The influence of specific inhibitors of MAO A (clorgyline) and MAO B [(-)deprenyl] on the metabolism of normetanephrine (NMN) in strips of canine saphenous vein was studied, both in the absence and in the presence of inhibitors of neuronal (cocaine) and extraneuronal (hydrocortisone) uptake. Moreover, the formation of metabolites of noradrenaline and of NMN by saphenous vein homogenates and the influence of clorgyline or (-)deprenyl on this formation are described. Clorgyline reduced to the same degree (by about 70%) the formation of methoxy-hydroxy-phenylglycol (MOPEG) and of vanillylmandelic acid (VMA) in strips incubated with NMN, whereas (-)deprenyl reduced by about 50% the formation of MOPEG and had no effect on VMA production. Hydrocortisone had effects very similar to those of (-)deprenyl. Saphenous vein homogenates (O-methylation inhibited), deaminated both noradrenaline and NMN; clorgyline and (-)deprenyl reduced the formation of metabolites of both noradrenaline and NMN. It is concluded that both MAO A and B are able to deaminate noradrenaline and NMN, but that in the intact tissue the former has no access to MAO B. Even in intact tissues MAO B may play a role in the metabolism (but not in the inactivation) of noradrenaline by deaminating the NMN formed from noradrenaline and giving preferentially origin to MOPEG.
研究了单胺氧化酶A(氯吉兰)和单胺氧化酶B((-)司来吉兰)的特异性抑制剂对犬隐静脉条中去甲变肾上腺素(NMN)代谢的影响,实验分别在不存在和存在神经元摄取抑制剂(可卡因)及非神经元摄取抑制剂(氢化可的松)的情况下进行。此外,还描述了隐静脉匀浆中去甲肾上腺素和NMN代谢产物的形成,以及氯吉兰或(-)司来吉兰对此形成过程的影响。氯吉兰使与NMN一起孵育的静脉条中3-甲氧基-4-羟基苯乙二醇(MOPEG)和香草扁桃酸(VMA)的形成减少到相同程度(约70%),而(-)司来吉兰使MOPEG的形成减少约50%,对VMA的产生没有影响。氢化可的松的作用与(-)司来吉兰非常相似。隐静脉匀浆(O-甲基化被抑制)使去甲肾上腺素和NMN均发生脱氨基作用;氯吉兰和(-)司来吉兰减少了去甲肾上腺素和NMN代谢产物的形成。得出的结论是,单胺氧化酶A和B都能够使去甲肾上腺素和NMN脱氨基,但在完整组织中,前者无法接触到单胺氧化酶B。即使在完整组织中,单胺氧化酶B也可能通过使由去甲肾上腺素形成的NMN脱氨基并优先产生MOPEG,在去甲肾上腺素的代谢(而非失活)中发挥作用。